Should we ignore covariate imbalance and stop presenting a stratified 'table one' for randomized trials? ( 2 3 ) [research methods] (42)
Advice for Pooling Two RCTs in Studying Risk Factors for Chronic Pain [data analysis] (12)
Has this JAMA Patient Page at last threaded the needle of explaining p-values? [general] (16)
Most reasonably hypothesised effects cannot be exactly zero? [study interpretation] (8)
What data can be recorded from patients who do not consent to be in a study? [general] (8)
Inverse probability weighting for treatment selection and loss to follow up in observational studies [data analysis] (16)
Can this be a possible statistical solution for a mid-trial realization? [design] (9)
Joint models for longitudinal and time-to-event data analysis applied to RCTs [modeling strategy] (4)
When or whether do we need to classify the continuous variable [journal club] (20)
Computing Information Loss [study interpretation] (3)
Time dependent variable with time dependent coefficient (at the same time) [general] (5)
Choosing penalty parameters for elastic net [variable selection] (4)
Proposal for a different way to analyze multivariate treatment safety outcomes [interpret] (1)
Bayesian approach to diagnostic validity? [bayes] (3)
Question on modeling repeated outcomes among single patients [models] (10)
Detecting clinical transition states in time series matrix data [research methods] (4)
What is type I error? ( 2 3 ) [formal] (51)
Charlson Comorbidity Index or Something Better? [general] (3)
Prevalence and probability [models] (4)
Troponin, its use and misuse to rule-out and rule-in heart attacks ( 2 3 ) [modeling strategy] (56)
Clustering with categorical data [general] (2)
Differential misclassification of the outcome (by exposure status) [data problems] (3)
Confidence score for survival model [uncertainty] (3)
Survival Analysis with Multiple Endpoints [general] (3)
Absolute risk measures from count models [formal] (7)
Calibration of Cox model [model validation] (2)
Protocol deviation and its impact on stat analysis [design] (9)
Disentangling Competing Risks with and without Endogeneity [research methods] (2)
Nosek et al paper [research methods] (19)
What does interaction between treatment and propensity to treat signify? [observational] (11)